公开(公告)号：US20170312207A1

公开(公告)日：2017-11-02

申请号：US15520254

申请日：2015-11-10

Applicant: SHOWA DENKO K.K.

Inventor： Yuko SAEKI ,  Eiko KATO

IPC: A61K8/60 ,  A61K8/06 ,  A61Q19/00

CPC classification number: A61K8/60 ,  A61K8/06 ,  A61K8/602 ,  A61K8/73 ,  A61K9/0014 ,  A61K9/107 ,  A61K31/7034 ,  A61K47/44 ,  A61K2800/78 ,  A61Q19/00 ,  A61Q19/08

Abstract: The present invention provides a moisturizing agent including an inositol derivative as an active ingredient in which saccharide of three or more monosaccharide unit is bonded to per molecule of inositol.

公开(公告)号：US20170143608A1

公开(公告)日：2017-05-25

申请号：US15323506

申请日：2015-08-12

Applicant: SHOWA DENKO K.K.

Inventor： Yuko SAEKI

IPC: A61K8/67 ,  A61Q19/02

CPC classification number: A61K8/678 ,  A61K31/661 ,  A61Q19/00 ,  A61Q19/02

Abstract: A tocopherol phosphoric acid ester represented by a following formula (1) (in the formula, R1, R2, and R3 each independently represents a hydrogen atom or a methyl group,), a pharmacologically-acceptable salt thereof, or a solvate thereof for use in the improvement of skin color.

公开(公告)号：US20170312301A1

公开(公告)日：2017-11-02

申请号：US15521427

申请日：2015-07-23

Applicant: SHOWA DENKO K.K.

Inventor： Yuko SAEKI ,  Eiko KATO

IPC: A61K31/7034 ,  A61Q17/00 ,  A61K8/60

CPC classification number: A61K31/7034 ,  A61K8/602 ,  A61K8/73 ,  A61K31/7032 ,  A61K2800/78 ,  A61Q17/00 ,  A61Q19/00 ,  A61Q19/08

Abstract: The present invention provides a skin barrier function-improving agent including an inositol derivative as an active ingredient in which inositol and saccharide are bonded, and a composition for improving a skin barrier function including the above skin barrier function-improving agent and a pharmacologically acceptable carrier.

公开(公告)号：US20170312200A1

公开(公告)日：2017-11-02

申请号：US15521464

申请日：2015-10-20

Applicant: SHOWA DENKO K.K.

Inventor： Yuko SAEKI

IPC: A61K8/37 ,  C07C67/08 ,  C07C67/03 ,  A61Q19/08 ,  A61Q19/00 ,  C07C67/317 ,  A61K8/06

CPC classification number: A61K8/37 ,  A61K8/06 ,  A61K8/33 ,  A61K8/365 ,  A61K31/22 ,  A61Q19/00 ,  A61Q19/08 ,  C07C67/03 ,  C07C67/08 ,  C07C67/317

Abstract: Provided is an agent for improving mitochondrial function including a hydroxycitric acid derivative represented by the following Formula (I) or a salt thereof, as an active ingredient [(In Formula (I), R1 and R2 each independently represent a hydrogen atom or any one group selected from the group represented by the following Formula (Ia) (here, R1 and R2 do not represent hydrogen atoms at the same time), X1 to X3 each independently represent a nitrogen or an oxygen atom, and R3, R4, R5, R3′ R4′, and R5′ each independently represent a hydrogen atom, or a chained hydrocarbon group (here, in a case where X1, X2, and X3 each independently represent an oxygen atom, corresponding R3′, R4′, or R5′ does not exist). In Formula (Ia), R6 to R8 each independently represent a hydrogen atom, an aryl group, or a chained hydrocarbon group having 1 to 30 carbon atoms].